Aurolife FDA Monday, August 31, 2015 0.00 Neutral

FDA Approves METHADONE HYDROCHLORIDE — Aurolife Pharma, LLC

# FDA Approves Aurolife Pharma's Generic Methadone Hydrochloride Aurolife Pharma, LLC has received FDA approval for its generic methadone hydrochloride oral formulation, expanding the competitive landscape in the opioid addiction treatment market and potentially lowering costs for patients dependent on this widely-used medication. The approval is expected to intensify price competition in the methadone segment while increasing patient access to this critical pain management and addiction treatment therapy.

View original filing at SEC.gov →
AI-generated summary for informational purposes only. Always verify against the original filing. Not investment advice. BriefTape is not a registered investment adviser.

Get real-time financial news in your trading bot or app

GET FREE KEY — 10,000 calls/day